Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Journal | Oxford Academic https://t.co/JPEVntSJPC
It's time for chronotherapy to receive more attention. https://t.co/Zck1vcxMMD
RT @DRKAMALAYOUB: دراسة على ١٩٠٠٠ مريض مصاب بالضغط وجدت ان تناول ادوية الضغط مساء قبل النوم ادى الى تقليل احتمالية الوفاة من امراض القلب وت…
RT @RiceMason: Bed time is the best time to take #bloodpressure #medication. Largest study finds greater reduction in risk of #cardiovascul…
دراسة على ١٩٠٠٠ مريض مصاب بالضغط وجدت ان تناول ادوية الضغط مساء قبل النوم ادى الى تقليل احتمالية الوفاة من امراض القلب وتحكم افضل بالضغط . https://t.co/lLsTcWVYHC
Bed time is the best time to take #bloodpressure #medication. Largest study finds greater reduction in risk of #cardiovascular disease and death from bedtime rather than morning medication: https://t.co/DOFKEZjXsD. Paper at: @ESC_Journals @OxfordJournals:
RT @OUPMedicine: Blood pressure medication taken at bedtime reduces the risk of major cardiovascular events, according to a new study publi…
I’m intrigued by this but need to do a deep dive into the methods. What say ye @thebyrdlab @DaichiShimbo @adambress @jordy_bc @jordanbking ?
Blood pressure medication taken at bedtime reduces the risk of major cardiovascular events, according to a new study published in the @ESC_Journals https://t.co/oD2RvrNCzm #cardiotwitter #hypertension https://t.co/voZQuFqdHJ
RT @ESC_Journals: Routine ingestion by hypertensive patients of BP-lowering medications at bedtime, as opposed to upon waking, resulted in…
RT @DrRajivsankar: Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Jo…
#Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/Rh2FRUmkyt
A lot to like about this latest Chronotherapy for hypertension trial https://t.co/gHG7ilxTNZ 1 - Do we now need to treat people according to a night-time BP target? 2- How can we increase the acceptability of 24hr ABPM for patients in order to monitor thi
this is HUGE https://t.co/EAFU6w152j
RT @ESC_Journals: Routine ingestion by hypertensive patients of BP-lowering medications at bedtime, as opposed to upon waking, resulted in…
Routine ingestion by hypertensive patients of BP-lowering medications at bedtime, as opposed to upon waking, resulted in improved BP control and markedly diminished occurrence of major CV events https://t.co/9BfaVMdQrc @escardio #EHJ @TomLuscher #cardiotw
RT @h_aldhefairi: دراسة منشورة في مجلة القلب الأوروبية: تناول أدوية ارتفاع ضغط الدم في المساء يعطي نتائج أفضل في إنزال الضغط و تجنب مضاعف…
RT @UCLStrokeRes: Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/SQ8URts…
RT @DrRajivsankar: Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Jo…
RT @DrRajivsankar: Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Jo…
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Journal | Oxford Academic @AnastasiaSMihai #hypertension https://t.co/VzUUEynbWe
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/SQ8URtsMGl
Should this change practice? Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/jPve8k4nrL
Another trial showing benefits of simple chronotherapy. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/me0CVWQ2Fh
RT @GeriSoc: 'Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial' via @ESC_Journals https…
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial via European Heart Journal https://t.co/dBXUhrDm4k
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Journal | Oxford Academic https://t.co/PFxLTMs6hd
RT @GeriSoc: 'Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial' via @ESC_Journals https…
It is good to be a night time dipper. 👇🏻
Blood pressure medication is best taken in the evening according to this new study https://t.co/kw0O2SUupY
RT @AmarPut: In the news today- @drkevinfernando @drpatrickholmes @kamleshkhunti @docwas @mmamas1973 @DrDerekConnolly @GauravGulsin @BrJCar…
Bedtime hypertension treatment improves CV risk reduction: Hygia Chronotherapy Trial European Heart Journal. @EHJ https://t.co/puKU79NWzd 6.3-year patient follow-up, 1752 participants. Evening Rx = primary CVD outcome 0.55 (0.50–0.61), P < 0.001. Beats
RT @farmaciabarbera: Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart…
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/FpbZwwcqjy
RT @GeriSoc: 'Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial' via @ESC_Journals https…
RT @GeriSoc: 'Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial' via @ESC_Journals https…
Game changer? https://t.co/WDlsZFiymJ
'Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial' via @ESC_Journals https://t.co/oO1sqaH9xn
RT @AmarPut: In the news today- @drkevinfernando @drpatrickholmes @kamleshkhunti @docwas @mmamas1973 @DrDerekConnolly @GauravGulsin @BrJCar…
RT @farmaciabarbera: Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart…
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Journal | Oxford Academic #chronotherapy https://t.co/m6JZlyWATF
tansiyon ilacını yatmadan almak daha etkiliymiş diyorlar https://t.co/TGt7xix7IH
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/TBcScih0UY intriguing study. follows up on what they and others have shown on the importance of nocturnal BP for CV outcomes. Home BP monitor
RT @drsarahjdavies: Fascinating primary care based study - change in practice to advise taking antihypertensives at night? https://t.co/BWi…
Fascinating primary care based study - change in practice to advise taking antihypertensives at night?
RT @AmarPut: In the news today- @drkevinfernando @drpatrickholmes @kamleshkhunti @docwas @mmamas1973 @DrDerekConnolly @GauravGulsin @BrJCar…
RT @RJTAdams: We clinicians need to be a lot more aware of the important effects of circadian and daily rhythms on treatments, especially m…
RT @AmarPut: In the news today- @drkevinfernando @drpatrickholmes @kamleshkhunti @docwas @mmamas1973 @DrDerekConnolly @GauravGulsin @BrJCar…
RT @AmarPut: In the news today- @drkevinfernando @drpatrickholmes @kamleshkhunti @docwas @mmamas1973 @DrDerekConnolly @GauravGulsin @BrJCar…
In the news today- @drkevinfernando @drpatrickholmes @kamleshkhunti @docwas @mmamas1973 @DrDerekConnolly @GauravGulsin @BrJCardiol @DSNforumUK @AbdTahrani Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
RT @kojima_aponet: multicentre, controlled, prospective endpoint trial。 降圧剤は寝る前に服用した方が心血管イベントを減らす 【Eur Heart J】 Bedtime hypertension trea…
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
RT @gt_hta: Bedtime #hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial #MFyC https://t.co/o88KY…
Routine ingestion by #HTA patients of ≥1 prescribed BP-lowering medications💊at bedtime, as opposed to upon waking, results in improved ABP control (significantly enhanced decrease in asleep BP and increased sleep-time relative BP decline, i.e. BP dipping)
RT @gt_hta: Bedtime #hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial #MFyC https://t.co/o88KY…
RT @gt_hta: Bedtime #hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial #MFyC https://t.co/o88KY…
Bedtime #hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial #MFyC https://t.co/o88KYtnLUq https://t.co/tDfWkGIPvD
RT @kojima_aponet: multicentre, controlled, prospective endpoint trial。 降圧剤は寝る前に服用した方が心血管イベントを減らす 【Eur Heart J】 Bedtime hypertension trea…
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial | European Heart Journal | Oxford Academic https://t.co/ULCGtlpYqN
RT @kojima_aponet: multicentre, controlled, prospective endpoint trial。 降圧剤は寝る前に服用した方が心血管イベントを減らす 【Eur Heart J】 Bedtime hypertension trea…
RT @kojima_aponet: multicentre, controlled, prospective endpoint trial。 降圧剤は寝る前に服用した方が心血管イベントを減らす 【Eur Heart J】 Bedtime hypertension trea…
multicentre, controlled, prospective endpoint trial。 降圧剤は寝る前に服用した方が心血管イベントを減らす 【Eur Heart J】 Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/UrsIspjAUB
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
RT @georgeta: Chronotherapy in HTN. Effect size in this RCT is impressive: Bedtime meds vs. morning, CVD death HR: 0.44 (0.34–0.56) --> Bed…
Chronotherapy in HTN. Effect size in this RCT is impressive: Bedtime meds vs. morning, CVD death HR: 0.44 (0.34–0.56) --> Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/T5rmHSKYAC
CHronothery strikes again: Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/2BW8JtgtyF @irene_moroni
Bedtime hypertension treatment improves cardiovascular risk reduction: Interesting finding could taking anti hypertension medications at bedtime prevent adverse outcome through alleviating autonomic disturbances during #sleep? @EuroRespSoc https://t.co/
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
@pabeda1 @CardioIAN @AnastasiaSMihai @MihaiTrofenciuc @J_Hendriks1 @Hragy @cpgale3 @AtulPathak31 Thanks for sharing this Hey, Swap @hswapnil, more from Hermida & colleagues https://t.co/J53YdV97ma
Practice Changing - Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction in Randomized Trial ($) https://t.co/Y6ecYVjLOj Commentary: https://t.co/9yBat8HNtc
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
Keeping eyes on our health. #fbSatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients followed for ~6 years. https://t.co/6cayMbfcSj https://t.co/1YaboyHMwf
RT @SatchinPanda: Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients f…
Obviously, we need to see all the details. But it sounds like a landmark practice-changing study. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial https://t.co/QdvqUTIRZ6
Same blood pressure medication taken at bedtime is more potent than taken in the morning. Results from ~19,000 patients followed for ~6 years. https://t.co/Bx4FDmagUJ https://t.co/0biH7xyf0D